Gotowe bibliografie tematyczne / Inborn errors of immunity

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji

Gotowa bibliografia na temat „Inborn errors of immunity”

Autor: Grafiati
Data publikacji: 1 lutego 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Inborn errors of immunity”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Inborn errors of immunity"

1

Moutsopoulos, N. M., M. S. Lionakis i G. Hajishengallis. "Inborn Errors in Immunity". Journal of Dental Research 94, nr 6 (21.04.2015): 753–58. http://dx.doi.org/10.1177/0022034515583533.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Baloh, Carolyn H., i Hey Chong. "Inborn Errors of Immunity". Medical Clinics of North America 108, nr 4 (lipiec 2024): 703–18. http://dx.doi.org/10.1016/j.mcna.2023.08.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Mizoguchi, Yoko, i Satoshi Okada. "Inborn errors of STAT1 immunity". Current Opinion in Immunology 72 (październik 2021): 59–64. http://dx.doi.org/10.1016/j.coi.2021.02.009.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Parlar, Yavuz Emre, Sefika Nur Ayar, Deniz Cagdas i Yasemin H. Balaban. "Liver immunity, autoimmunity, and inborn errors of immunity". World Journal of Hepatology 15, nr 1 (27.01.2023): 52–67. http://dx.doi.org/10.4254/wjh.v15.i1.52.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Tiri, Alessandra, Riccardo Masetti, Francesca Conti, Anna Tignanelli, Elena Turrini, Patrizia Bertolini, Susanna Esposito i Andrea Pession. "Inborn Errors of Immunity and Cancer". Biology 10, nr 4 (9.04.2021): 313. http://dx.doi.org/10.3390/biology10040313.

Pełny tekst źródła
Streszczenie:
Inborn Errors of Immunity (IEI) are a heterogeneous group of disorders characterized by a defect in the function of at least one, and often more, components of the immune system. The aim of this narrative review is to discuss the epidemiology, the pathogenesis and the correct management of tumours in patients with IEI. PubMed was used to search for all of the studies published over the last 20 years using the keywords: “inborn errors of immunity” or “primary immunodeficiency” and “cancer” or “tumour” or “malignancy”. Literature analysis showed that the overall risk for cancer in children with IEI ranges from 4 to 25%. Several factors, namely, age of the patient, viral infection status and IEI type can influence the development of different cancer types. The knowledge of a specific tumour risk in the presence of IEI highlights the importance of a synergistic effort by immunologists and oncologists in tracking down the potential development of cancer in known IEI patients, as well as an underlying IEI in patients with newly diagnosed cancers. In the current genomic era, the creation of an international registry of IEI cases integrated with malignancies occurrence information is fundamental to optimizing the diagnostic process and to evaluating the outcomes of new therapeutic options, with the hope to obtain a better prognosis for these patients.
Style APA, Harvard, Vancouver, ISO itp.
6

Seth, Neha, Karen S. Tuano i Javier Chinen. "Inborn errors of immunity: Recent progress". Journal of Allergy and Clinical Immunology 148, nr 6 (grudzień 2021): 1442–50. http://dx.doi.org/10.1016/j.jaci.2021.10.010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Casanova, Jean-Laurent, i Laurent Abel. "Inborn errors of immunity to infection". Journal of Experimental Medicine 202, nr 2 (18.07.2005): 197–201. http://dx.doi.org/10.1084/jem.20050854.

Pełny tekst źródła
Streszczenie:
The immune system's function is to protect against microorganisms, but infection is nonetheless the most frequent cause of death in human history. Until the last century, life expectancy was only ∼25 years. Recent increases in human life span primarily reflect the development of hygiene, vaccines, and anti-infectious drugs, rather than the adjustment of our immune system to coevolving microbes by natural selection. We argue here that most individuals retain a natural vulnerability to infectious diseases, reflecting a great diversity of inborn errors of immunity.
Style APA, Harvard, Vancouver, ISO itp.
8

Fernandes Pineda, Mónica, i Andrés F. Zea-Vera. "From phenotypic to molecular diagnosis: Insights from a clinical immunology service focused on inborn errors of immunity in Colombia". Biomédica 44, Sp. 2 (23.12.2024): 168–77. https://doi.org/10.7705/biomedica.7533.

Pełny tekst źródła
Streszczenie:
Introduction. Inborn errors of immunity include a broad spectrum of genetic diseases, in which a specific gene mutation might alter the entire emphasis and approach for an individual patient.Objective. To conduct a comprehensive analysis of the correlation between phenotypic and molecular diagnoses in patients with confirmed inborn errors of immunity at a tertiary hospital in Cali, Colombia.Materials and methods. We conducted a retrospective study in which we sequentially evaluated all available institutional medical records with a diagnosis of inborn errors of immunity.Results. In the Clinical Immunology Service of the Hospital Universitario del Valle, 517 patients were evaluated. According to the IUIS-2022 classification, 92 patients (17.35%) were definitively diagnosed with an inborn error of immunity. Of these, 38 patients underwent genetic studies. The most prevalent category was predominantly antibody deficiencies (group III) (38/92 - 41.3%). A broad spectrum of genetic defects, novel and previously reported, were described, including mutations in the following genes: ATM, BTK, ERBIN, MAB21L2, RAG2, SAVI, SH2D1A, STAT1, SYK, and TMEM173. Less frequent findings included cases of the WHIM syndrome, SYK gain-of-function, and IL-7 deficiency.Conclusions. The establishment of the Clinical Immunology Service in the Hospital Universitario del Valle has emerged as a pivotal resource, catering to individuals with limited financial means and covered by public health insurance within the southwest region of Colombia. Molecular genetics confirmatory diagnosis was achieved in 38 patients (41.3%) with inborn errors of immunity and changed the diagnosis in 24 cases (26%).
Style APA, Harvard, Vancouver, ISO itp.
9

Lona-Reyes, Juan Carlos, María Enriqueta Núnez-Núñez, Denisse Monraz-Monteón, Luis Iván Pozos-Ochoa, Diego Magallón-Picazo i Beatriz Bayardo-Gutierrez. "Neumonía necrosante en un paciente con deficiencia selectiva de IgA". Revista Alergia México 71, nr 3 (30.09.2024): 205–11. https://doi.org/10.29262/ram.v71i3.1344.

Pełny tekst źródła
Streszczenie:
Background: Inborn errors of immunity originate from monogenic mutations that should be considered in the suggestive diagnosis of patients with recurrent or severe infections, allergies, autoimmunity, autoinflammatory diseases, bone marrow failure and malignancy. Case report: Pediatric patient, male, 4 years old, treated in the medical service for fever of 39°C, difficult to control. The simple chest x-ray reported left pulmonary consolidation. The infectious condition evolved into necrotizing pneumonia of the left upper lobe, so it was decided to perform a lobectomy. The diagnosis of some inborn error of immunity was suspected. The determination of serum immunoglobulins reported IgA below the reference values. At 4 years he continued to have decreased serum IgA (5.5 mg/dL). Conclusion: The diagnosis of selective IgA deficiency is established after 4 years of life; However, due to the patient’s severe infection, addressing some inborn error of immunity had to be implemented. Keywords: Recurrent infections; Inborn error of immunity; Necrotizing pneumonia; Lobectomy; IgA; Selective IgA deficiency.
Style APA, Harvard, Vancouver, ISO itp.
10

Martín, María Luz, Maximiliano Ezequiel Frías, Laura Del Pino, Débora Velázquez, Victor Skrie, Beatriz María Inés Pereira i Julio César Orellana. "Asociación entre alteraciones del perfil linfoide ampliado por citometría de flujo y errores innatos de la inmunidad". Revista Alergia México 71, nr 3 (30.09.2024): 155–68. https://doi.org/10.29262/ram.v71i3.1381.

Pełny tekst źródła
Streszczenie:
Objective: To evaluate the association between the expanded lymphoid profile and inborn errors of immunity using flow cytometry. Methods: Observational and cross-sectional, case-control study, carried out in patients with a diagnosis or clinical suspicion of inborn errors of immunity, treated at the Santísima Trinidad Children’s Hospital in Córdoba, Argentina, from August 2021 to November 2022. Clinical data were collected, and peripheral blood samples were obtained for flow cytometry analysis, using the PIDOT tube, to identify lymphocyte subpopulations. For statistical analysis, Fisher’s exact test, odds ratio and binary logistic regression model were used. Results: 40 cases and 20 controls were analyzed. The most frequently altered lymphocyte subpopulations were: CD4+ n (63%), Mem c/s (60%) and Mem s/s (55%). A statistically significant association was found between several lymphocyte subpopulations and health-disease status. Binary logistic regression reported Mem s/s and CD4+n as altered lymphocyte subpopulations with a greater probability to have inborn errors of immunity. Conclusion: This study contributes to improving the understanding of inborn errors of immunity and demonstrates a strong association with altered lymphocyte subpopulation profiles. Mem s/s and CD4+n emerge as relevant biomarkers for diagnosis. Heterogeneity in different diseases and in flow cytometry underlines the importance of evaluating each patient individually, to improve diagnosis and treatment. Keywords: Inborn errors of immunity; Flow cytometry; Lymphocyte subpopulations; Diagnostic markers.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Inborn errors of immunity"

1

Idani, Aida. "A multiomics approach to primary immunodeficiencies in human". Electronic Thesis or Diss., Strasbourg, 2024. http://www.theses.fr/2024STRAJ061.

Pełny tekst źródła
Streszczenie:
Les déficits immunitaires primitifs sont un groupe de troubles causés par des mutations monogéniques dans des gènes jouant un rôle clé dans le développement et la fonction du système immunitaire. Dans cette thèse, une approche multiomique a été adoptée pour étudier deux gènes associés à ces conditions, afin d'élucider davantage les mécanismes par lesquels les variants pathogènes nuisent au système immunitaire. Le premier sujet était HYOU1, défini comme un gène dont les défauts causent un déficit immunitaire primitif. Nous avons observé une hypogranularité dans les neutrophiles du patient et révélé un arrêt de maturation dans la lignée des cellules B avant le stade des cellules B pro. Le deuxième sujet était ITGAL, un gène candidat potentiel non précédemment décrit en relation avec les déficits immunitaires primitifs. Nous avons démontré que le variant étudié est hérité selon un mode autosomique récessif, et les analyses de voies ont révélé un dysfonctionnement de plusieurs voies liées à l'adhésion et à la motilité. De plus, nous avons montré une élévation de l'expression d'autres intégrines, suggérant une réponse compensatoire visant à contrebalancer les intégrines défectueuses
Primary immunodeficiencies, or inborn errors of immunity, are a group of disorders caused by monogenic mutations in genes playing a key role in the development and function of the immune system. In this thesis, a multiomics approach was taken to study two genes associated with these conditions, further elucidating the mechanisms by which pathogenic variants impair the immune system. The first subject was HYOU1, defined as a gene whose defects cause primary immunodeficiency. We observed hypogranularity in the patient's neutrophils and revealed a maturation arrest in the B cell lineage before the pro-B cell stage. The second subject was ITGAL, a potential candidate gene not previously described in relation to primary immunodeficiencies. We demonstrated that the studied variant is inherited in an autosomal recessive pattern, and pathway analyses revealed impairment of multiple adhesion and motility-related pathways. Moreover, we showed an elevation in the expression of other integrins, suggesting a compensatory response to counterbalance the defective integrins
Style APA, Harvard, Vancouver, ISO itp.
2

Ristoff, Ellinor. "Inborn errors in the metabolism of glutathione /". Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-392-9/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Pastore, Nunzia. "Gene therapy for inborn errors of metabolism". Thesis, Open University, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590807.

Pełny tekst źródła
Streszczenie:
Inborn errors of liver metabolism are frequent causes of morbidity and mortality especially in children. For several of these diseases, treatment approaches depend on ,manipulation of the affected metabolic pathway by diet, drugs, vitamin cofactors, enzyme induction, end-product replacement, and alternative pathway activation. Unfortunately, these approaches often remain unsatisfactory especially in the face of illness or catabolism. Ideally, transfer of the normal genes in the liver cells that are defective might restore the metabolic function. The goal of my PhD thesis was to develop gene-based therapeutic strategies to correct a life-threatening inborn error of liver metabolism, Crigler-Najjar syndrome type I (CNI). CNI is a severe inborn error of bilirubin metabolism due to mutations of the uridine diphospho-glucuronosyl transferase lAl (UGTIA1) gene, Affected patients have elevations of serum bilirubin, and they have to spend extended hours under bilirubin lights throughout childhood and adolescence. Despite this therapy, they remain at risk of brain damage when intercurrent infections may increase production of bilirubin above that which can be controlled by the bilirubin light therapy. Thus, patients with CNI often are advised to consider liver transplantation. Therefore, alternative therapies are highly needed to overcome the mortality and morbidity associated with transplantation procedure, and risks of life-long immunosuppression. Gene therapy has the potential to provide a definitive cure for patient with CNI My studies have focused on the development of gene therapy strategies for this disease. First, I investigated in Gunn rats, the animal model for CNI, the efficacy of adeno-associated viral (AA V) vector-mediated muscledirected gene therapy and I found that serotype I AA V vector expressing UOTIAI resulted in expression of UGTIAl protein and functionally active enzyme in injected muscles, and aj 50% reduction in serum bilirubin levels for at least 1 year post-injection. Taken together, these data show that clinically relevant and sustained reduction of serum bilirubin levels can be achieved by simple and safe intramuscular injections. Following initial problems with intravenous injections of AA V2 vector, a major success has been achieved with AA V2/8 vectors for liver-directed gene therapy of hemophilia. Encouraged by these results and by the possibility of achieving full correction of the hyperbilirubineotia with systemic delivery, next I focused on the design and optimization of an AA V2I8 vector for liver-directed gene therapy of CNI. I generated multiple expression cassettes expressing the UGTIAl gene inserted into the AA V2/8 vectors for in vivo testing. The results of these studies showed that AAV2/8 vector with codon optimized UGTlAI gene tender the control of the hepatocyte-specific LP} promoter resulted in improved and sustained correction of hyperbilirubinemia in Gunn rats. Taken together, these data demonstrate the development of an optimal expression cassette for liver-directed gene therapy of CNI and form the preclinical basis for the development of a gene therapy trial for this severe disorder.
Style APA, Harvard, Vancouver, ISO itp.
4

Kocic, Vesna Garovic. "Methionine auxotrophy in inborn errors of cobalamin metabolism". Thesis, McGill University, 1992. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=56756.

Pełny tekst źródła
Streszczenie:
Several of the inborn errors of vitamin B$ sb{12}$ (cobalamin, Cbl) metabolism (cblC, cblD, cblE, cblF, cblG) are associated with homocystinuria and hypomethioninemia due to a functional deficiency of the cytoplasmic enzyme methionine synthase which requires methylcobalamin (MeCbl) as a cofactor. We compared the growth of cultured fibroblasts from controls with those from patients with a selective deficiency of MeCbl (cblE and cblG) and with those from patients with a defect in both MeCbl and adenosylcobalamin (AdoCbl) (cblC, cblD and cblF). Cells were grown in methionine and folic acid free media and in fully supplemented medium. Control cells were able to grow in the deficient medium supplied with homocysteine, cobalamin and folate, while mutant cells were not, due to their inability to synthesize methionine from its immediate metabolic precursor, homocysteine. This differential growth is useful for screening for genetic defects of methionine biosynthesis. Moreover, by correcting methionine auxotrophy in these cells, it may be possible to isolate genes which code for the products that are deficient in these disorders.
Style APA, Harvard, Vancouver, ISO itp.
5

Byck, Susan. "Cross-correctional studies in inborn errors of vitamin B12 metabolism". Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=59259.

Pełny tekst źródła
Streszczenie:
Human skin fibroblasts derived from patients with all 7 known inborn errors of vitamin B$ sb{12}$ metabolism have been studied for functional integrity of methylmalonyl CoA mutase and methionine synthase. Cocultivation of cblC and cblF fibroblasts in the absence of polyethylene glycol resulted in a twofold increase over the expected in both ($ sp{14}$C) propionate and ($ sp{14}$C) methyltetrahydrofolate incorporation into acid-precipitable material, suggesting that metabolic cooperation between cells occurs. CblD fibroblasts, which are biochemically similar to cblC cells (Goodman et al, 1970; Willard et al, 1977), do not cooperate metabolically when mixed with cblF cells. Partial correction in phenotype was seen in mixtures of cblD and cblG cells, but not cblC and cblG cells. These observations lend further support for the division of cblC and cblD disease into two discrete complementation classes. Cocultivation of cblF fibroblasts with both cblE and cblG cells also resulted in partial correction in phenotype.
($ sp{14}$C) Propionate incorporation in both cblC and cblF cells exposed to conditioned medium from control cells was increased more than twofold. ($ sp{14}$C) methyltetrahydrofolate incorporation in cblC cells exposed to conditioned medium from cblF cells was increased twofold. This suggests the presence of a diffusible factor correcting the defect in the mutant cell lines.
Style APA, Harvard, Vancouver, ISO itp.
6

Black, Duncan Arthur. "Aspects of purine and pyrimidine metabolism". Doctoral thesis, University of Cape Town, 1989. http://hdl.handle.net/11427/26590.

Pełny tekst źródła
Streszczenie:
In Chapter 1 a review of the literature concerning aspects of erythrocyte membrane transport and metabolism, and purine and pyrimidine metabolism is presented. The effects of pH, pO₂ and inorganic phosphate (Pi) on the uptake and metabolism of hypoxanthine by erythrocytes has been studied in Chapter 2. Uptake of hypoxanthine and accumulation of inosine 5'-monophosphate (IMP) were markedly increased at acid pH, high external phosphate concentrations, and low pO₂. Release of accumulated IMP as hypoxanthine occurred at alkaline pH values and low external phosphate concentrations. Conditions favouring IMP accumulation gave rise, in the absence of hypoxanthine, to a corresponding increase in 5'-phosphoribosyl-1-pyrophosphate (PRPP). Intracellular phosphate concentrations were markedly pH dependent and a model is presented whereby hypoxanthine uptake and release are controlled by intracellular concentrations of inorganic phosphate and 2,3- bisphosphoglycerate (2,3-DPG). These allosteric effectors influence, in opposing ways, two enzymes governing IMP accumulation, namely PRPP synthetase and 5'-nucleotidase. These metabolic properties suggest that the erythrocyte could play a role in the removal of hypoxanthine from anoxic tissue. In Chapter 3 the kinetics and mechanism of transport of orotate across the human erythrocyte membrane and the effect of pH and inorganic phosphate on its metabolism (in the erythrocyte) have been studied. It has been shown that orotate enters erythrocytes with non-saturable kinetics and with a capacity of 190 μmoles/1 packed cells/min at a concentration of 4-6 mmolar. The presence of competition for transport by a number of anions and the lack of competition by uridine is indicative of transport by a general anion transporter, with the ability for concentrative uptake in the absence of other external anions being compatible with transport via a ping-pong mechanism. Inhibition of transport by the specific band 3 inhibitors DIDS and CHCA confirm that transport is via the band 3 anion transporter. This explains the lack of significant uptake of orotate by most differentiated tissues which lack the intact band 3 protein. However, the demonstration of band 3 in rat hepatocytes (Cheng and Levy, 1980) provides a mechanism for the orotate transport which has been observed in liver (Handschumacher and Coleridge, 1979). Changes in pH and inorganic phosphate (Pi) concentrations have been shown to have marked effects on the relative quantities of metabolic products produced by the erythrocyte from orotate. There was an increase in orotate metabolised with increasing Pi, an effect augmented by lowering the pH, and most easily explained by the allosteric activation of PRPP synthetase by Pi. The increase in UTP levels with decreasing pH may be the consequence of both increased PRPP availability for the formation of uridine nucleotide from orotate, and decreased conversion of UMP to uridine by pyrimidine 5'-nucleotidase, which is known to be inhibited by phosphate. The accumulation of UDP sugars is optimal at a phosphate concentration of 10 mmolar, which is unexplained but would be compatible with an inhibitory effect of Pi on CTP synthetase. A PRPP wasting cycle at alkaline pH values is proposed to explain the apparent paradox where no PRPP was observed to accumulate in erythrocytes (Chapter 2) at pH values of 7.6 and above in the presence of 10 mmolar phosphate and no added hypoxanthine, yet the metabolism of orotate, which is a PRPP utilising reaction, at alkaline pH values was readily demonstrable here. This (apparent paradox) can be resolved if one assumes that even in the absence of added hypoxanthine and demonstrable intracellular IMP there are sufficient quantities of hypoxanthine and/or IMP to maintain a PRPP wasting cycle at alkaline pH values. The cycle is interrupted at acidic pH values as phosphate levels rise and inhibit 5'-nucleotidase, an effect augmented by the decreasing levels of 2,3-DPG which accompany decreasing pH. This wasting cycle has recently been confirmed by P. Berman (unpublished). The kinetics of orotate uptake by erythrocytes and its eventual release as uridine provides a role for the erythrocyte in the transport and distribution of pyrimidines to peripheral tissues. A model is proposed and involves the de novo production of orotate in the liver. In the next step erythrocytes take up the orotate secreted by the liver into the circulation, convert it into an intermediate buffer store of uridine nucleotides, whose distribution is a function of pH and phosphate concentration, and eventually release it as uridine, which is a readily available form of pyrimidine for utilisation by peripheral nucleated cells. The enhancement of uptake of labelled orotate into nucleic acids of cultured cells is demonstrated here. The degradative half of the cycle proposes that uracil and palanine are the predominant degradative forms of pyrimidines produced by peripheral cells, and their ultimate metabolic fate is complete catabolism in the liver to CO₂ and water. In the final chapter the possible role of the human erythrocyte in the prevention of reperfusion injury has been investigated. The development of a model of renal ischaemia in the rat is described. The ability of human erythrocytes, "primed" by preincubating in acid medium of high Pi concentration and low pO₂, to take up hypoxanthine in a concentrative manner when perfused through ischaemic rat kidney is demonstrated. Attempts to demonstrate improved survival and renal function in rats with "primed" human erythrocytes prior to reperfusion were, however, unsuccessful. It is further demonstrated that "unprimed" human erythrocytes, resident in ischaemic rat kidney for 3 hours, take up hypoxanthine and convert it to IMP. that erythrocytes could play a physiological prevention of reperfusion injury.
Style APA, Harvard, Vancouver, ISO itp.
7

Moras, Emily. "Mitochondrial cobalamin binding proteins in patients with inborn errors of cobalamin metabolism". Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=97972.

Pełny tekst źródła
Streszczenie:
Vitamin B12 (cobalamin, Cbl) is required as a cofactor for two human enzymes: methylmalonyl-CoA mutase (MCM) and methionine synthase (MS). Fibroblasts from patients with inborn errors of cobalamin metabolism have been classified into nine distinct complementation classes ( cblA-cblH and mut). Previous studies have shown that cobalamin binds MCM in mitochondria and MS in the cytosol. Cobalamin binding patterns were analyzed in crude mitochondrial fractions obtained from normal and mutant fibroblasts. Crude mitochondrial fractions from wildtype fibroblasts confirmed that the majority of [57Co]Cbl eluted with MCM. However, in six of the nine disorders, at least one previously unidentified mitochondrial cobalamin binding protein was observed to bind [57Co]Cbl. The proportion of [57Co]Cbl that binds, is increased when a deficiency in either adenosylcobalamin synthesis or utilization prevents binding to MCM. Furthermore, unique cobalamin binding profiles emerged, demonstrating how known mutations in these patients affect cobalamin binding to accessory proteins.
Style APA, Harvard, Vancouver, ISO itp.
8

MIGNANI, LUCA. "Study of inborn errors of Coenzyme A biosynthesis using Danio rerio animal models". Doctoral thesis, Università degli studi di Brescia, 2022. http://hdl.handle.net/11379/558461.

Pełny tekst źródła
Streszczenie:
Animal models are widely used to investigate the pathogenesis and molecular processes involved in the development and progression of human diseases. The Danio rerio, assumed a predominant role in the last decade due to some characteristics such as ease of use, the high number of embryos obtainable, the possibility to follow embryonic development and a completely sequenced genome. Neurodegeneration with Brain Iron Accumulation (NBIA) is a family of diseases characterized by a peculiar accumulation of iron in the brain. All known forms of NBIA are induced by mutations in single genes that code for proteins involved in different pathways. PKAN and CoPAN are two neuropathologies of this group, respectively caused by mutations in PANK2 and COASY genes, which encode for proteins directly involved in the synthesis of Coenzyme A. The transient downregulation of the two zebrafish orthologues of PANK2 and CoASY, respectively pank2 and coasy, induces the onset of specific phenotypes comparable to human pathologies, suggesting the possibility of using Danio rerio as a model for the study of XXX and a tool to discover potential therapeutic strategies. The study was followed by the generation of Knock-Out models for pank2 and coasy and their subsequent characterization. CRISPR/Cas9 technology was used, which allowed us to obtain mutant lines for pank2 and coasy. Analysis performed on pank2 Knock-Out, revealed no significant changes in gene expression that could compensate the lack of pank2 (pank1a and pank1b), or in genes that could compensate the absence of the protein (coasy). However, Western Blot analysis demonstrated a significant reduction in pank2 levels in mutant embryos. Based on previously obtained data which indicated aberrant neuronal development, evaluation of the nervous system development of mutant embryos and the brains of adult individuals was performed using several techniques. The results obtained do not show significant defects in the development of the main neuronal regions both in embryos and in mutant adults. The analysis of the vascular system instead highlighted a morphological alteration at the level of the caudal venous plexus. This results partially confirms what was found in Knock-Down models, suggesting the importance of pank2 for the correct development of the vessels. Specific stains for primordial germ cells showed a decrease in this population in mutant embryos at early stages of development, defects that are probably implicated in the testicular atrophy observed in adults of 1 year of age. This result is similar to what was observed in the mouse model for PKAN which is mainly characterized by azoospermia. A preliminary analysis of the behaviour of the mutant larvae did not reveal any particular difference, while the study of the stress-induced response in adults showed a decrease in the behaviour associated with stress in the mutants. The results indicate that pank2 is involved in various pathways in zebrafish, specifically the formation of vessels, the correct development of germ cells and in the neural circuits involved in the stress response. Furthermore, we successfully generated a CoPAN model in zebrafish inducing mutations in coasy. To date, the phenotypical analysis of this model demonstrate that individuals carrying homozygotes mutation cannot reach adulthood and die before day 15 of development. We also noted the absence of swimming bladder in mutant individuals at 5 days of development. Further analyses will be carried out to better understand the mechanisms that link the onset of this phenotype and the lack of coasy. In conclusion, we generated two models one for for inborn errors of CoA biosynthesis in Danio rerio, their characterization highlights different phenotypes related to the absence of pank2 and coasy that could be useful to better understand the mechanisms underlying these pathologies and can be used to screen molecules with therapeutic potential.
I modelli animali vengono utilizzati per investigare la patogenesi e i processi molecolari coinvolti nell’insorgenza di malattie umane. Danio rerio, ha assunto nell’ultimo decennio un ruolo predominante per via di alcune caratteristiche come la facilità d’utilizzo, l’elevato numero di embrioni ottenibili, la possibilità di seguire lo sviluppo embrionale e un genoma completamente sequenziato. Con il termine Neurodegenerazione con accumulo di ferro cerebrale (NBIA) si indica una famiglia di malattie, caratterizzate da un accumulo di ferro a livello cerebrale. Tutte le forme di NBIA conosciute sono indotte da mutazioni in singoli geni che codificano per proteine coinvolte in diversi processi cellulari. PKAN e CoPAN sono due di queste patologie causate rispettivamente da mutazioni dei geni PANK2 e COASY, che codificano per proteine coinvolte nella sintesi del Coenzima A. La downregolazione dei due ortologhi di zebrafish di PANK2 e CoASY, rispettivamente pank2 e coasy, ha dimostrato l’insorgenza di fenotipi paragonabili alle patologie umane suggerendo la possibilità di usare Danio rerio come modello per lo studio di PKAN e CoPAN. Lo studio è proseguito con la generazione di modelli Knock-Out per pank2 e coasy e dalla loro caratterizzazione. È stata utilizzata la tecnologia CRISPR/Cas9, che ha permesso di ottenere linee mutanti per pank2 e coasy. L’analisi di espressione genica sui KO di pank2 non ha rilevato cambiamenti significativi in geni che potrebbero sopperire alla funzione di pank2 (pank1a e pank1b), o in geni coinvolti nella sintesi del CoA (coasy). Analisi dei livelli proteici hanno dimostrato una significativa riduzione dei livelli di pank2 negli embrioni mutanti. Sulla base dei dati ottenuti in precedenza che indicavano uno sviluppo neuronale aberrante, è stata eseguita una valutazione dello sviluppo del sistema nervoso degli embrioni e del cervello di individui adulti utilizzando diverse tecniche. I risultati ottenuti dimostrano che sia negli embrioni che negli adulti mutanti non sono presenti rilevanti difetti nello sviluppo delle principali aree neuronali. L’analisi del sistema vascolare ha evidenziato un’alterazione morfologica del plesso venoso causale, risultato che conferma in parte quello visto in modelli KO per pank2 suggerendo ulteriormente l’importanza di pank2 nello sviluppo dei vasi. È stata osservata una diminuzione del numero di cellule primordiali germinali negli embrioni, difetti che probabilmente è implicato nell’atrofia testicolare osservata negli individui adulti. Questo risultato è in linea con quanto documentato nel modello murino per PKAN che è caratterizzato soprattutto per azoospermia. Un’analisi comportamentale delle larve non ha rilevato alcuna differenza, mentre lo studio della risposta indotta da stress nell’adulto ha dimostrato una diminuzione del comportamento associato a stress nei mutanti. I risultati ottenuti ci hanno permesso di dimostrare che pank2 è implicato in diversi pathways in zebrafish, nello specifico la formazione di vasi, nel corretto sviluppo di cellule germinali e nei circuiti neurali implicati nella risposta allo stress. Il secondo obiettivo della nostra analisi è stata la generazione di una linea mutante per coasy, creando un modello di CoPAN in zebrafish. La caratterizzazione di questo modello a livello fenotipo ha dimostrato che individui omozigoti per la mutazione non riesco a raggiungere lo stadio adulto ma muoiono entro il 15 giorno di sviluppo, inoltre è stata documentata l’assenza della vescia natatoria in individui mutanti a 5 giorni. Ulteriori analisi andranno effettuate per meglio comprendere i meccanismi che legano questo fenotipo alla mancanza di coasy. I risultati ottenuti evidenziano differenze rispetto ai controlli che potrebbero essere utili per comprendere i meccanismi alla base di queste patologie e/o per lo screening di potenziali target terapeutici.
Style APA, Harvard, Vancouver, ISO itp.
9

MIGNANI, LUCA. "Study of inborn errors of Coenzyme A biosynthesis using Danio rerio animal models". Doctoral thesis, Università degli studi di Brescia, 2022. http://hdl.handle.net/11379/558476.

Pełny tekst źródła
Streszczenie:
Animal models are widely used to investigate the pathogenesis and molecular processes involved in the development and progression of human diseases. The Danio rerio, assumed a predominant role in the last decade due to some characteristics such as ease of use, the high number of embryos obtainable, the possibility to follow embryonic development and a completely sequenced genome. Neurodegeneration with Brain Iron Accumulation (NBIA) is a family of diseases characterized by a peculiar accumulation of iron in the brain. All known forms of NBIA are induced by mutations in single genes that code for proteins involved in different pathways. PKAN and CoPAN are two neuropathologies of this group, respectively caused by mutations in PANK2 and COASY genes, which encode for proteins directly involved in the synthesis of Coenzyme A. The transient downregulation of the two zebrafish orthologues of PANK2 and CoASY, respectively pank2 and coasy, induces the onset of specific phenotypes comparable to human pathologies, suggesting the possibility of using Danio rerio as a model for the study of XXX and a tool to discover potential therapeutic strategies. The study was followed by the generation of Knock-Out models for pank2 and coasy and their subsequent characterization. CRISPR/Cas9 technology was used, which allowed us to obtain mutant lines for pank2 and coasy. Analysis performed on pank2 Knock-Out, revealed no significant changes in gene expression that could compensate the lack of pank2 (pank1a and pank1b), or in genes that could compensate the absence of the protein (coasy). However, Western Blot analysis demonstrated a significant reduction in pank2 levels in mutant embryos. Based on previously obtained data which indicated aberrant neuronal development, evaluation of the nervous system development of mutant embryos and the brains of adult individuals was performed using several techniques. The results obtained do not show significant defects in the development of the main neuronal regions both in embryos and in mutant adults. The analysis of the vascular system instead highlighted a morphological alteration at the level of the caudal venous plexus. This results partially confirms what was found in Knock-Down models, suggesting the importance of pank2 for the correct development of the vessels. Specific stains for primordial germ cells showed a decrease in this population in mutant embryos at early stages of development, defects that are probably implicated in the testicular atrophy observed in adults of 1 year of age. This result is similar to what was observed in the mouse model for PKAN which is mainly characterized by azoospermia. A preliminary analysis of the behaviour of the mutant larvae did not reveal any particular difference, while the study of the stress-induced response in adults showed a decrease in the behaviour associated with stress in the mutants. The results indicate that pank2 is involved in various pathways in zebrafish, specifically the formation of vessels, the correct development of germ cells and in the neural circuits involved in the stress response. Furthermore, we successfully generated a CoPAN model in zebrafish inducing mutations in coasy. To date, the phenotypical analysis of this model demonstrate that individuals carrying homozygotes mutation cannot reach adulthood and die before day 15 of development. We also noted the absence of swimming bladder in mutant individuals at 5 days of development. Further analyses will be carried out to better understand the mechanisms that link the onset of this phenotype and the lack of coasy. In conclusion, we generated two models one for for inborn errors of CoA biosynthesis in Danio rerio, their characterization highlights different phenotypes related to the absence of pank2 and coasy that could be useful to better understand the mechanisms underlying these pathologies and can be used to screen molecules with therapeutic potential.
I modelli animali vengono utilizzati per investigare la patogenesi e i processi molecolari coinvolti nell’insorgenza di malattie umane. Danio rerio, ha assunto nell’ultimo decennio un ruolo predominante per via di alcune caratteristiche come la facilità d’utilizzo, l’elevato numero di embrioni ottenibili, la possibilità di seguire lo sviluppo embrionale e un genoma completamente sequenziato. Con il termine Neurodegenerazione con accumulo di ferro cerebrale (NBIA) si indica una famiglia di malattie, caratterizzate da un accumulo di ferro a livello cerebrale. Tutte le forme di NBIA conosciute sono indotte da mutazioni in singoli geni che codificano per proteine coinvolte in diversi processi cellulari. PKAN e CoPAN sono due di queste patologie causate rispettivamente da mutazioni dei geni PANK2 e COASY, che codificano per proteine coinvolte nella sintesi del Coenzima A. La downregolazione dei due ortologhi di zebrafish di PANK2 e CoASY, rispettivamente pank2 e coasy, ha dimostrato l’insorgenza di fenotipi paragonabili alle patologie umane suggerendo la possibilità di usare Danio rerio come modello per lo studio di PKAN e CoPAN. Lo studio è proseguito con la generazione di modelli Knock-Out per pank2 e coasy e dalla loro caratterizzazione. È stata utilizzata la tecnologia CRISPR/Cas9, che ha permesso di ottenere linee mutanti per pank2 e coasy. L’analisi di espressione genica sui KO di pank2 non ha rilevato cambiamenti significativi in geni che potrebbero sopperire alla funzione di pank2 (pank1a e pank1b), o in geni coinvolti nella sintesi del CoA (coasy). Analisi dei livelli proteici hanno dimostrato una significativa riduzione dei livelli di pank2 negli embrioni mutanti. Sulla base dei dati ottenuti in precedenza che indicavano uno sviluppo neuronale aberrante, è stata eseguita una valutazione dello sviluppo del sistema nervoso degli embrioni e del cervello di individui adulti utilizzando diverse tecniche. I risultati ottenuti dimostrano che sia negli embrioni che negli adulti mutanti non sono presenti rilevanti difetti nello sviluppo delle principali aree neuronali. L’analisi del sistema vascolare ha evidenziato un’alterazione morfologica del plesso venoso causale, risultato che conferma in parte quello visto in modelli KO per pank2 suggerendo ulteriormente l’importanza di pank2 nello sviluppo dei vasi. È stata osservata una diminuzione del numero di cellule primordiali germinali negli embrioni, difetti che probabilmente è implicato nell’atrofia testicolare osservata negli individui adulti. Questo risultato è in linea con quanto documentato nel modello murino per PKAN che è caratterizzato soprattutto per azoospermia. Un’analisi comportamentale delle larve non ha rilevato alcuna differenza, mentre lo studio della risposta indotta da stress nell’adulto ha dimostrato una diminuzione del comportamento associato a stress nei mutanti. I risultati ottenuti ci hanno permesso di dimostrare che pank2 è implicato in diversi pathways in zebrafish, nello specifico la formazione di vasi, nel corretto sviluppo di cellule germinali e nei circuiti neurali implicati nella risposta allo stress. Il secondo obiettivo della nostra analisi è stata la generazione di una linea mutante per coasy, creando un modello di CoPAN in zebrafish. La caratterizzazione di questo modello a livello fenotipo ha dimostrato che individui omozigoti per la mutazione non riesco a raggiungere lo stadio adulto ma muoiono entro il 15 giorno di sviluppo, inoltre è stata documentata l’assenza della vescia natatoria in individui mutanti a 5 giorni. Ulteriori analisi andranno effettuate per meglio comprendere i meccanismi che legano questo fenotipo alla mancanza di coasy. I risultati ottenuti evidenziano differenze rispetto ai controlli che potrebbero essere utili per comprendere i meccanismi alla base di queste patologie e/o per lo screening di potenziali target terapeutici.
Style APA, Harvard, Vancouver, ISO itp.
10

MIGNANI, LUCA. "Study of inborn errors of Coenzyme A biosynthesis using Danio rerio animal models". Doctoral thesis, Università degli studi di Brescia, 2022. http://hdl.handle.net/11379/558458.

Pełny tekst źródła
Streszczenie:
Animal models are widely used to investigate the pathogenesis and molecular processes involved in the development and progression of human diseases. The Danio rerio, assumed a predominant role in the last decade due to some characteristics such as ease of use, the high number of embryos obtainable, the possibility to follow embryonic development and a completely sequenced genome. Neurodegeneration with Brain Iron Accumulation (NBIA) is a family of diseases characterized by a peculiar accumulation of iron in the brain. All known forms of NBIA are induced by mutations in single genes that code for proteins involved in different pathways. PKAN and CoPAN are two neuropathologies of this group, respectively caused by mutations in PANK2 and COASY genes, which encode for proteins directly involved in the synthesis of Coenzyme A. The transient downregulation of the two zebrafish orthologues of PANK2 and CoASY, respectively pank2 and coasy, induces the onset of specific phenotypes comparable to human pathologies, suggesting the possibility of using Danio rerio as a model for the study of XXX and a tool to discover potential therapeutic strategies. The study was followed by the generation of Knock-Out models for pank2 and coasy and their subsequent characterization. CRISPR/Cas9 technology was used, which allowed us to obtain mutant lines for pank2 and coasy. Analysis performed on pank2 Knock-Out, revealed no significant changes in gene expression that could compensate the lack of pank2 (pank1a and pank1b), or in genes that could compensate the absence of the protein (coasy). However, Western Blot analysis demonstrated a significant reduction in pank2 levels in mutant embryos. Based on previously obtained data which indicated aberrant neuronal development, evaluation of the nervous system development of mutant embryos and the brains of adult individuals was performed using several techniques. The results obtained do not show significant defects in the development of the main neuronal regions both in embryos and in mutant adults. The analysis of the vascular system instead highlighted a morphological alteration at the level of the caudal venous plexus. This results partially confirms what was found in Knock-Down models, suggesting the importance of pank2 for the correct development of the vessels. Specific stains for primordial germ cells showed a decrease in this population in mutant embryos at early stages of development, defects that are probably implicated in the testicular atrophy observed in adults of 1 year of age. This result is similar to what was observed in the mouse model for PKAN which is mainly characterized by azoospermia. A preliminary analysis of the behaviour of the mutant larvae did not reveal any particular difference, while the study of the stress-induced response in adults showed a decrease in the behaviour associated with stress in the mutants. The results indicate that pank2 is involved in various pathways in zebrafish, specifically the formation of vessels, the correct development of germ cells and in the neural circuits involved in the stress response. Furthermore, we successfully generated a CoPAN model in zebrafish inducing mutations in coasy. To date, the phenotypical analysis of this model demonstrate that individuals carrying homozygotes mutation cannot reach adulthood and die before day 15 of development. We also noted the absence of swimming bladder in mutant individuals at 5 days of development. Further analyses will be carried out to better understand the mechanisms that link the onset of this phenotype and the lack of coasy. In conclusion, we generated two models one for for inborn errors of CoA biosynthesis in Danio rerio, their characterization highlights different phenotypes related to the absence of pank2 and coasy that could be useful to better understand the mechanisms underlying these pathologies and can be used to screen molecules with therapeutic potential.
I modelli animali vengono utilizzati per investigare la patogenesi e i processi molecolari coinvolti nell’insorgenza di malattie umane. Danio rerio, ha assunto nell’ultimo decennio un ruolo predominante per via di alcune caratteristiche come la facilità d’utilizzo, l’elevato numero di embrioni ottenibili, la possibilità di seguire lo sviluppo embrionale e un genoma completamente sequenziato. Con il termine Neurodegenerazione con accumulo di ferro cerebrale (NBIA) si indica una famiglia di malattie, caratterizzate da un accumulo di ferro a livello cerebrale. Tutte le forme di NBIA conosciute sono indotte da mutazioni in singoli geni che codificano per proteine coinvolte in diversi processi cellulari. PKAN e CoPAN sono due di queste patologie causate rispettivamente da mutazioni dei geni PANK2 e COASY, che codificano per proteine coinvolte nella sintesi del Coenzima A. La downregolazione dei due ortologhi di zebrafish di PANK2 e CoASY, rispettivamente pank2 e coasy, ha dimostrato l’insorgenza di fenotipi paragonabili alle patologie umane suggerendo la possibilità di usare Danio rerio come modello per lo studio di PKAN e CoPAN. Lo studio è proseguito con la generazione di modelli Knock-Out per pank2 e coasy e dalla loro caratterizzazione. È stata utilizzata la tecnologia CRISPR/Cas9, che ha permesso di ottenere linee mutanti per pank2 e coasy. L’analisi di espressione genica sui KO di pank2 non ha rilevato cambiamenti significativi in geni che potrebbero sopperire alla funzione di pank2 (pank1a e pank1b), o in geni coinvolti nella sintesi del CoA (coasy). Analisi dei livelli proteici hanno dimostrato una significativa riduzione dei livelli di pank2 negli embrioni mutanti. Sulla base dei dati ottenuti in precedenza che indicavano uno sviluppo neuronale aberrante, è stata eseguita una valutazione dello sviluppo del sistema nervoso degli embrioni e del cervello di individui adulti utilizzando diverse tecniche. I risultati ottenuti dimostrano che sia negli embrioni che negli adulti mutanti non sono presenti rilevanti difetti nello sviluppo delle principali aree neuronali. L’analisi del sistema vascolare ha evidenziato un’alterazione morfologica del plesso venoso causale, risultato che conferma in parte quello visto in modelli KO per pank2 suggerendo ulteriormente l’importanza di pank2 nello sviluppo dei vasi. È stata osservata una diminuzione del numero di cellule primordiali germinali negli embrioni, difetti che probabilmente è implicato nell’atrofia testicolare osservata negli individui adulti. Questo risultato è in linea con quanto documentato nel modello murino per PKAN che è caratterizzato soprattutto per azoospermia. Un’analisi comportamentale delle larve non ha rilevato alcuna differenza, mentre lo studio della risposta indotta da stress nell’adulto ha dimostrato una diminuzione del comportamento associato a stress nei mutanti. I risultati ottenuti ci hanno permesso di dimostrare che pank2 è implicato in diversi pathways in zebrafish, nello specifico la formazione di vasi, nel corretto sviluppo di cellule germinali e nei circuiti neurali implicati nella risposta allo stress. Il secondo obiettivo della nostra analisi è stata la generazione di una linea mutante per coasy, creando un modello di CoPAN in zebrafish. La caratterizzazione di questo modello a livello fenotipo ha dimostrato che individui omozigoti per la mutazione non riesco a raggiungere lo stadio adulto ma muoiono entro il 15 giorno di sviluppo, inoltre è stata documentata l’assenza della vescia natatoria in individui mutanti a 5 giorni. Ulteriori analisi andranno effettuate per meglio comprendere i meccanismi che legano questo fenotipo alla mancanza di coasy. I risultati ottenuti evidenziano differenze rispetto ai controlli che potrebbero essere utili per comprendere i meccanismi alla base di queste patologie e/o per lo screening di potenziali target terapeutici.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Inborn errors of immunity"

1

Casanova, Jean-Laurent, Mary Ellen Conley i Luigi Notarangelo. The year in human and medical genetics: Inborn errors of immunity I. Redaktor New York Academy of Sciences. Boston, Mass: Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Jürgen, Schaub, Van Hoof François 1935-, Vis H. L, Nestlé Nutrition S. A i Nestlé Nutrition Workshop (24th : 1989 : Brussels, Belgium), red. Inborn errors of metabolism. New York: Raven Press, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

H, Fensom Anthony, red. Genetic biochemical disorders. Oxford: Oxford University Press, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Benson, P. F. Genetic biochemical disorders. Oxford [Oxfordshire]: Oxford University Press, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

H, Fensom Anthony, red. Genetic biochemical disorders. Oxford: Oxford University Press, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Houser, Christine M. Pediatric Genetics and Inborn Errors of Metabolism. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0581-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Kari, Carol. Gaucher's disease: A nurse's handbook : Clinical Center. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Office of Clinical Reports and Inquiries, Clinical Center, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Salzer, Elisabeth. Identifying Novel Inborn Errors of the Immune System. Wiesbaden: Springer Fachmedien Wiesbaden, 2017. http://dx.doi.org/10.1007/978-3-658-16796-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

1921-, Fernandes J., Saudubray J. M. 1937- i Van den Berghe, Georges, 1938-, red. Inborn metabolic diseases: Diagnosis and treatment. Wyd. 2. Berlin: Springer-Verlag, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

J, Shaw Duncan, red. Molecular genetics of human inherited disease. Chichester: Wiley, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Inborn errors of immunity"

1

Albert, Michael H., Arjan Lankester, Andrew Gennery i Bénédicte Neven. "Inborn Errors of Immunity". W The EBMT Handbook, 809–17. Cham: Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_90.

Pełny tekst źródła
Streszczenie:
AbstractInborn errors of immunity (IEI) comprise diseases arising from genetic defects that lead to abnormalities in immune cell development or function with a wide spectrum in severity and clinical manifestations. The number of transplants for IEI has increased significantly over the last years, elicited by better insight in the pathogenesis of the IEI (and thus the “curability” of these diseases with allo-HCT), better outcomes even with unrelated and haploidentical donors, and more differentiated approaches to HCT including reduced toxicity conditioning regimens.
Style APA, Harvard, Vancouver, ISO itp.
2

Hedayat, Mona, Waleed Al-Herz, Asghar Aghamohammadi, Kim E. Nichols i Nima Rezaei. "Inborn Errors of Immunity and Cancers". W Cancer Immunology, 545–83. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-30845-2_25.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Reid, Whitney, i Neil Romberg. "Inborn Errors of Immunity and Cytokine Storm Syndromes". W Advances in Experimental Medicine and Biology, 185–207. Cham: Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-59815-9_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kamboj, Manmohan K. "Inborn Errors of Metabolism". W Neurodevelopmental Disabilities, 53–67. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-0627-9_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Holzman, Robert S., Thomas J. Mancuso, Navil F. Sethna i James A. DiNardo. "Inborn Errors of Metabolism". W Pediatric Anesthesiology Review, 377–86. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1617-4_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Holzman, Robert S. "Inborn Errors of Metabolism". W Pediatric Anesthesiology Review, 607–20. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-60656-5_43.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Holzman, Robert S. "Inborn Errors of Metabolism". W Pediatric Anesthesiology Review, 435–45. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48448-8_30.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Arnemann, J. "Inborn errors of metabolism". W Springer Reference Medizin, 1239–40. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_3508.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Arnemann, J. "Inborn errors of metabolism". W Lexikon der Medizinischen Laboratoriumsdiagnostik, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_3508-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Goetsch, Allison L., Dana Kimelman i Teresa K. Woodruff. "Inborn Errors of Metabolism". W Fertility Preservation and Restoration for Patients with Complex Medical Conditions, 113–39. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-52316-3_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Inborn errors of immunity"

1

Khaksari, Kosar, Wei-Liang Chen, Sasha Santiago i Andrea Gropman. "Brain biomarkers of inborn errors of metabolism using fNIRS". W Clinical and Translational Neurophotonics 2025, redaktorzy Jana M. Kainerstorfer, Erin M. Buckley i Vivek J. Srinivasan, 50. SPIE, 2025. https://doi.org/10.1117/12.3059219.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Batani, V., E. Benetti, J. Mahajne, F. Segala, C. Minici, M. Lanzillotta, D. Colavito i E. Della Torre. "POS0376 HUMAN INBORN ERRORS OF IMMUNITY IN IgG4 RELATED DISEASE". W EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.3221.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Busack, Leonie Marie, Stephanie Thee, Yvonne Liu, Christine Allomba, Niklas Ziegahn, Apolline Tosolini, Charlotte O. Pioch i in. "Multiple-breath washout for the detection of lung disease in patients with inborn errors of immunity". W ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa4472.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Andrea, Largent, Kathi Lambert, Chiang Kristy, Shumlak Natali, Quan-Zhen Li, Kelly Hudkins, Denny Liggitt i in. "203 Insights into lupus biology from inborn errors of immunity: immunopathogenesis of STAT1 gain-of- function autoimmunity". W LUPUS 21ST CENTURY 2022 CONFERENCE, Abstracts of Sixth Scientific Meeting of North American and European Lupus Community, Tucson, AZ, USA – September 20–23, 2022. Lupus Foundation of America, 2022. http://dx.doi.org/10.1136/lupus-2022-lupus21century.7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Cunha, Daniela, Brenno Gonçalves, Tamiris Barros i Andréa Silva. "A variant found in the RELA gene in a patient with autoinflammatory disease: Inborn Errors of Immunity?" W International Symposium on Immunobiologicals. Instituto de Tecnologia em Imunobiológicos, 2022. http://dx.doi.org/10.35259/isi.2022_52181.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Sampagar, Abhilasha, Sudeep Gaddam i Anushree Cm. "1637 Spectrum of cases of inborn errors of immunity and their clinical and laboratory profile: a case series from a tertiary care hospital in South India". W Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference–Online, 15 June 2021–17 June 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-rcpch.762.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Fatouh, Mohamed. "597 Organization and provision of services for better management of inborn errors of metabolism". W Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Liverpool, 28–30 June 2022. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2022. http://dx.doi.org/10.1136/archdischild-2022-rcpch.320.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Siddiqui, Duygu Özbek, i Leyla Tümer. "200 Do doctors know what they do not know about inborn errors of metabolism". W Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Glasgow, 23–25 May 2023. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2023. http://dx.doi.org/10.1136/archdischild-2023-rcpch.275.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Zaitseva, Ekaterina. "APPLICATION OF GENOMIC RESEARCH TECHNOLOGIES FOR INNATE IMMUNITY ERRORS". W 6th SWS International Scientific Conference on Social Sciences ISCSS 2019. STEF92 Technology, 2019. http://dx.doi.org/10.5593/sws.iscss.2019.3/s12.051.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Stepchenkov, Yury A., Yury V. Rogdestvenski, Yury I. Shikunov, Denis Y. Diachenko i Yury G. Diachenko. "Improvement of Self-Timed Pipeline Immunity of Soft Errors". W 2021 IEEE Conference of Russian Young Researchers in Electrical and Electronic Engineering (ElConRus). IEEE, 2021. http://dx.doi.org/10.1109/elconrus51938.2021.9396125.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Inborn errors of immunity” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii